Chi Chiu Mok Selected Research

Lupus Nephritis

12/2022	Response to: 'Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis'' by Xu.
1/2022	The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
1/2021	Urinary Biomarkers in Lupus Nephritis: Are We There Yet?
7/2020	Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
1/2020	Author Correction: Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities.
1/2020	Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities.
1/2020	Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
1/2019	Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays.
1/2019	Is Treat-to-target in Lupus Nephritis Realistic in Clinical Practice?
11/2018	Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi Chiu Mok Research Topics

Disease

37	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2002
33	Lupus Nephritis 12/2022 - 04/2002
11	Rheumatoid Arthritis 12/2019 - 01/2007
9	Infections 07/2021 - 10/2003
8	Osteoporosis 01/2022 - 08/2008
8	Glomerulonephritis 01/2022 - 04/2002
4	Rheumatic Diseases (Rheumatism) 01/2022 - 11/2006
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2008
4	Hypertension (High Blood Pressure) 01/2019 - 08/2004
4	Nephritis 01/2019 - 04/2002
3	Herpes Zoster 07/2020 - 01/2019
3	Pain (Aches) 03/2020 - 01/2007
3	Atherosclerosis 01/2019 - 06/2011
3	Obesity 01/2019 - 09/2005
3	Inflammation (Inflammations) 01/2019 - 01/2015
3	Proteinuria 11/2018 - 08/2005
3	Tuberculosis (Tuberculoses) 03/2014 - 03/2011
3	Fatigue 05/2013 - 01/2007
3	Thromboembolism 03/2013 - 12/2005
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2013 - 08/2004
3	Psychotic Disorders (Schizoaffective Disorder) 01/2006 - 07/2003
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 09/2007
2	Chronic Renal Insufficiency 01/2019 - 01/2016
2	Diabetes Mellitus 01/2019 - 03/2013
2	Hepatitis 12/2018 - 03/2011
2	Hepatitis B 12/2018 - 12/2013
2	Opportunistic Infections (Opportunistic Infection) 02/2015 - 12/2013
2	Agammaglobulinemia (Hypogammaglobulinemia) 02/2015 - 12/2013
2	Renal Insufficiency (Renal Failure) 01/2015 - 05/2013
2	Thrombosis (Thrombus) 03/2013 - 07/2007
2	Serositis 03/2013 - 09/2005
2	Thrombophilia 05/2011 - 12/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022
1	Dermatomyositis (Dermatopolymyositis) 11/2022
1	Confusion (Bewilderment) 01/2022
1	Hip Fractures (Intertrochanteric Fractures) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021

Drug/Important Bio-Agent (IBA)

13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2020 - 04/2002
12	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2022 - 09/2002
11	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 08/2005
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
8	Biological ProductsIBA 12/2019 - 10/2006
8	CreatinineIBA 01/2016 - 04/2002
7	Antirheumatic Agents (DMARD)IBA 12/2019 - 01/2007
7	Estrogens (Estrogen)FDA Link 12/2019 - 09/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
6	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 08/2005
6	GlucocorticoidsIBA 03/2020 - 08/2008
6	Calcineurin InhibitorsIBA 01/2017 - 10/2006
6	Rituximab (Mabthera)FDA Link 02/2015 - 10/2006
5	Azathioprine (Imuran)FDA LinkGeneric 10/2016 - 04/2002
5	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2015 - 07/2003
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017 - 10/2003
4	Pharmaceutical PreparationsIBA 01/2017 - 01/2013
4	AntibodiesIBA 01/2017 - 01/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2014 - 01/2007
3	AutoantibodiesIBA 11/2022 - 02/2010
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2021 - 01/2016
3	VaccinesIBA 12/2019 - 05/2013
3	Etanercept (Enbrel)FDA Link 01/2017 - 01/2013
3	CalciumIBA 05/2013 - 12/2005
3	HDL CholesterolIBA 04/2012 - 09/2005
3	HDL LipoproteinsIBA 04/2012 - 09/2005
2	IFIH1 Interferon-Induced HelicaseIBA 11/2022 - 01/2022
2	AngiostatinsIBA 01/2022 - 11/2018
2	Denosumab FDA Link 01/2021 - 06/2015
2	Infliximab (Remicade)FDA Link 01/2017 - 01/2017
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2017
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 10/2006
2	Immunomodulating AgentsIBA 01/2017 - 10/2006
2	Immunoglobulin G (IgG)IBA 12/2013 - 01/2008
2	Vitamin D FDA LinkGeneric 05/2013 - 04/2012
2	Antimalarials (Antimalarial Agents)IBA 05/2013 - 09/2005
2	C-Reactive ProteinIBA 03/2013 - 06/2011
2	ametantrone (HAQ)IBA 01/2013 - 01/2007
2	Raloxifene Hydrochloride (Evista)FDA Link 05/2011 - 12/2005
2	Complement System Proteins (Complement)IBA 01/2010 - 07/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2008 - 10/2006
2	Antiphospholipid AntibodiesIBA 12/2005 - 09/2005
1	Complement C3 (C3 Complement)IBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	EnzymesIBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2022
1	Lipocalin-2IBA 01/2022
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2022
1	Codon (Codons)IBA 01/2021
1	Complement C4bIBA 01/2021
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2021
1	HLA-DRB1*04 antigenIBA 01/2021

Therapy/Procedure

25	Therapeutics 12/2022 - 04/2005
3	Biological Therapy 01/2019 - 06/2014
2	Drug Therapy (Chemotherapy) 03/2010 - 11/2006